Event: China Clinical Trials Leaders Summit 2017

Date: June 29, 2017

Venue: Parkyard Hotel, Shanghai, China

Weblink: www.clinicaltrialsleaders.com

Contact: Marketing Department

Tel: +86 21 3160 2153

Email: marketing@wbfgroup.com

Over the years, China has increasingly become the hotbed and destination for the clinical research. From one side, increasingly global pharmaceutical companies have recognized the importance and advantages to integrate China into the global early and late phase clinical development but also meanwhile the china clinical research markets are further driven and facilitated by the rapidly transforming China Local R&D Innovation.

A part of our highly successful Clinical Trials series, the event, which attracts over 150 attendees, will build upon CTLCS 2017 and examine partnerships and outsourcing strategies; key regulatory changes and the effects these have had on china market access; best practice techniques in clinical operations; Data Integrity, Quality & Risk Management; and also address the need to adopt Innovative Technology to ensure safety, transparency and quality as well as the hurdles of Oncology Drug Development ,Biologics & Biosimilar so as to keep up to date with the pace of growth in the region and maintain the clinical trials boom in Asia.

With over 20 speakers and estimation to bring over 150 clinical professionals, the key congress topics will cover:

•  Regulation,Outlook and Trend
• Compliance, Quality and Data Integrity
• Strategic Partnerships & Clinical Outsourcing
• Patient Centric, Site Selection and Project Management
• Innovation ,Technology and Analytics
• Oncology Drug Development ,Biologics & Biosimilar 

On behalf of the committee, we sincerely hope primary discussions, topics and invitees would come across your scientific and strategic interests and the whole summit will be consisted of keynote speeches, panel/roundtable discussions, open Q&A sessions, booth and poster exhibition and guided networking sessions for all professionals and management who are working for the drug development programs in china.